Researchers at John Hopkins University in Baltimore found that variations in a single gene can be used to predict if someone is likely to take their own life. Here’s the story. Interestingly, the same researchers also found a genetic marker
Here’s the first part of my column on the recent Congressional investigation into the genomcs industry: The genomics industry, which provides reports about disease risk, ancestry, and drug reactions based on one’s DNA, came under fire last week as a
It’s been a tough week for the personal genomics testing marketplace. First there were two long days of FDA meetings, and then today an Energy and Commerce Committee held hearings where the GAO announced the results of a “sting” operation
A press release today says that “IBM Research Aims to Build Nanoscale DNA Sequencer to Help Drive Down Cost of Personalized Genetic Analysis”. The release goes on to say that “This advanced research effort to demonstrate a silicon-based “DNA Transistor”
Here’s an informative article from h+ magazine on how the FDA currently argues that culturing adult stem cells amounts to the creation of a new drug. This of course would mean long time lags for getting stem cell procedures approved,
This is an interesting piece in the Economist about the upcoming personalized medicine revolution. Some people are skeptical that medicine really will be personalized, so Clayton Christensen of Harvard Business School has come up with a term that means “customization”,
The WSJ today reported that “New genetic research emerging from a major cancer meeting [annual meeting of the American Society of Clinical Oncology] could help doctors better identify the drugs most likely to work in their patients — but sharply
This is yet more step on the way to fully personalized medicine.Â The new test, which will analyzes blood or saliva samples, will soon be offered by ProActive Genomics.Â Here’s the full story from the NYT.